Patent Assignment
Reel/Frame 012931/0499
Merger
Recorded: 2002-05-24
Pages: 7
Assignor
GENE LOGIC ACQUISITION CORPORATION
Executed: 2001-11-01
Assignee
GENE LOGIC INC.
708 QUINCE ORCHARD ROAD, GAITHERSBURG, MARYLAND, 20878
Covered Properties
(30)
Susceptibility Mutation for Breast and Ovarian Cancer
Patent:
5,756,294 →
Application:
08/533,472 →
Consensus Sequence of the Human BRCA1 Gene
Patent:
5,654,155 →
Application:
08/598,591 →
Coding Sequences of the Human BRCA1 Gene
Patent:
5,750,400 →
Application:
08/798,691 →
Method for Identifying Variations in Polynucleotide Sequences
Patent:
6,048,689 →
Application:
08/825,487 →
Methods for Identifying and Determining the Relative Frequencies of the Most Common Functional Alleles in a Population
Application:
08/905,772 →
Consensus Sequence of the Human BRCA1 Gene
Application:
08/966,436 →
Mutations in the Brca 1 Gene
Application:
09/038,946 →
Novel Coding Sequence Haplotypes of the Human BRCA2 Gene
Application:
09/071,715 →
Coding Sequence Haplotype of the Human BRCA1 Gene
Application:
09/074,452 →
Coding Sequences of the Human BRCA1 Gene
Application:
09/074,453 →
Coding Sequences of the Human BRCA1 Gene
Patent:
6,130,322 →
Application:
09/074,476 →
Novel Coding Sequence Haplotypes of the Human BRCA2 Gene
Application:
09/084,471 →
Determining Common Functional Alleles in a Population and Uses Therefore
Application:
09/129,134 →
Susceptibility Mutation 6495DELGC of BRCA2
Patent:
6,492,109 →
Application:
09/158,183 →
Determining common functional alleles in a population and uses therefore
Application:
09/524,794 →
Mutations in the BRCA1 gene
Application:
09/697,149 →
Coding Sequences of the Human BRCA1 Gene
Method for Determining the Haplotype of a Human BRCA1 Gene
Coding sequences of the human BRCA1 gene
Application:
09/982,828 →
Publication:
US 2003/0022184
Mutations in the BRCA1 gene
Application:
09/982,835 →
Publication:
US 2003/0235819
Coding Sequence Haplotype of the Human BRCA1 Gene
Susceptibility Mutation 2799DELAA for Breast and Ovarian Cancer
Application:
60/022,421 →
Susceptibility Mutation 5053DE1G for Breast and Ovarian Cancer
Application:
60/023,184 →
Susceptibility Mutation 4158DELAG for Breast and Ovarian Cancer
Application:
60/023,187 →
Susceptibility Mutation 943INS10 for Breast and Ovarian Cancer
Application:
60/023,223 →
Novel Coding Sequences of the Human BRCA2 Gene
Application:
60/055,784 →
Susceptibility Mutation 6495DELGC of BRCA2
Application:
60/059,595 →
Gene Panel Assay for Susceptibility Mutations in Breast and Ovarian Cancer
Application:
60/059,729 →
Novel Coding Sequences of the Human BRCA2 Gene
Application:
60/064,926 →
Novel Coding Sequences of the Human BRCA2 Gene
Application:
60/065,367 →
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Dec 26, 1995
From: WHITE, MARGA D.; SADZEWICZ, LISA K.
To: ONCORMED, INC.
Reel/Frame 007756/0861 →
Assignment of Assignor's Interest
Jun 6, 1996
From: MURPHY, PATRICIA D.; ALLEN, ANTONETTE C.; ALVARES, CHRISTOPHER P.; CRITZ, BRENDA S.
To: ONCORMED, INC.
Reel/Frame 008118/0910 →
Assignment of Assignor's Interest
Jul 14, 1997
From: ALLEN, ANTONETTE C.; MURPHY, PATRICIA D.; ALVARES, CHRISTOPHER P.; CRITZ, BRENDA S.
To: ONCORMED, INC.
Reel/Frame 008600/0647 →
Assignment of Assignor's Interest
Oct 3, 1997
From: MURPHY, PATRICIA D.; WHITE, MARGA B.
To: ONCORMED, INC.
Reel/Frame 008774/0902 →
Assignment of Assignor's Interest
Oct 10, 1997
From: MURPHY, PATRICIA D.
To: ONCORMED, INC.
Reel/Frame 009161/0801 →
Assignment of Assignor's Interest
Apr 22, 1998
From: RABIN, MARK B.
To: ONCORMED, INC.
Reel/Frame 009132/0713 →
Assignment of Assignor's Interest
Jul 10, 1998
From: MURPHY, PATRICIA D.; ALLEN, ANTONETTE C.P.; ALVARES, CHRISTOPHER P.; CRITZ, BRENDA S.
To: ONCORMED, INC.
Reel/Frame 009331/0024 →
Assignment of Assignor's Interest
Aug 27, 1998
From: ALLEN, ANTONETTE C.P.; ANGELLY, TRACY S.; LAWRENCE, TAMMY; OLSON, SHERI J.
To: ONCORMED, INC.
Reel/Frame 009422/0975 →
Assignment of Assignor's Interest
Aug 28, 1998
From: MURPHY, PATRICIA D.; WHITE, MARGA B.; RABIN, MARK B.; OLSON, SHERI J.
To: ONCORMED, INC.
Reel/Frame 009412/0414 →
Assignment of Assignor's Interest
Aug 31, 1998
From: MURPHY, PATRICIA D.; ALLEN, ANTONETTE C.P.; ALVARES, CHRISTOPHER P.; CRITZ, BRENDA S.
To: ONCORMED, INC.
Reel/Frame 009417/0349 →
Assignment of Assignor's Interest
Oct 21, 1998
From: MURPHY, PATRICIA D.
To: ONCORMED, INC.
Reel/Frame 009532/0245 →
Assignment of Assignor's Interest
Feb 10, 1999
From: LESCALLET, JENNIFER L.; THURBER, DENISE B.
To: GENE LOGIC, INC.
Reel/Frame 009769/0333 →
Assignment of Assignor's Interest
Feb 23, 2000
From: ONCORMED, INC.
To: GENE LOGIC, INC.
Reel/Frame 010647/0707 →
Assignment of Assignor's Interest
Feb 29, 2000
From: MURPHY, PATRICIA D.; WHITE, MARGA B.; RABIN, MARK B.; OLSON, SHERI J.
To: ONCORMED, INC.
Reel/Frame 010409/0263 →
Assignment of Assignor's Interest
Mar 31, 2000
From: ONCORMED, INC.
To: GENE LOGIC, INC.
Reel/Frame 010721/0942 →
Merger
Feb 28, 2001
From: ONCORMED, INC.
To: GENE LOGIC ACQUISITION CORP
Reel/Frame 011585/0614 →
Merger
Jun 17, 2005
From: GENE LOGIC ACQUISITION CORP.
To: GENE LOGIC INC.
Reel/Frame 016357/0174 →
Assignment of Assignor's Interest
Jan 30, 2008
From: ORE PHARMACEUTICALS INC.
To: MYRIAD GENETICS INC.
Reel/Frame 020431/0882 →
Assignment of Assignor's Interest
Mar 10, 2010
From: ORE PHARMACEUTICALS, INC.
To: MYRIAD GENETICS, INC.
Reel/Frame 024055/0321 →
Assignment of Assignor's Interest
Mar 10, 2010
From: ORE PHARMACEUTICALS, INC.
To: MYRIAD GENETICS, INC.
Reel/Frame 024055/0316 →
Assignment of Assignor's Interest
Mar 10, 2010
From: ORE PHARMACEUTICALS, INC.
To: MYRIAD GENETICS, INC.
Reel/Frame 024055/0546 →
Assignment of Assignor's Interest
Mar 10, 2010
From: ORE PHARMACEUTICALS, INC.
To: MYRIAD GENETICS, INC.
Reel/Frame 024055/0525 →
Assignment of Assignor's Interest
Mar 10, 2010
From: ORE PHARMACEUTICALS, INC.
To: MYRIAD GENETICS, INC.
Reel/Frame 024055/0564 →
Assignment of Assignor's Interest
Mar 10, 2010
From: ORE PHARMACEUTICALS, INC.
To: MYRIAD GENETICS, INC.
Reel/Frame 024055/0559 →
Assignment of Assignor's Interest
Mar 10, 2010
From: ORE PHARMACEUTICALS, INC.
To: MYRIAD GENETICS, INC.
Reel/Frame 024055/0554 →